Elsevier Science Ltd.

SHERPA: Unknown

People

  1. O'Reilly
    O'Reilly
  2. Boelens
    Boelens
  3. Cancio
    Cancio
  4. Curran
    Curran
  5. Kernan
    Kernan
  6. Kung
    Kung
  7. Sadelain
    Sadelain
  8. Scaradavou
    Scaradavou
  9. Wang
    Wang

Groups

  1. Department of Medicine (4)
  2. GSK Faculty (4)
  3. Pediatrics, Department of (4)
  4. Sloan Kettering Institute Faculty (4)
  5. Stem Cell Transplantation and Cellular Therapy Service (4)
  6. Tow Center for Developmental Oncology (TCDO) (4)
  7. Center for Molecular Imaging and Biotechnology (3)
  8. Immunology Program Faculty (3)
  9. Center for Hematologic Malignancies (2)
  10. Executive Committee, Center for Hematologic Malignancies (1)
Search Within
  1. "2020"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
  3. Review (1)
Groups
  1. Department of Medicine (4)
  2. GSK Faculty (4)
  3. Pediatrics, Department of (4)
  4. Sloan Kettering Institute Faculty (4)
  5. Stem Cell Transplantation and Cellular Therapy Service (4)
  6. Tow Center for Developmental Oncology (TCDO) (4)

More Groups

People
  1. Richard O'Reilly (3)
  2. Susan Prockop (3)
  3. Ekaterina Doubrovina (2)
  4. Jaap Jan Boelens (2)
  5. Maria Cancio (2)
  6. Andrew Kung (1)

More People

Years
  1. 2020 (5)
Publications
  1. Cytotherapy (5)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emerging trends in COVID-19 treatment: Learning from inflammatory conditions associated with cellular therapies
    Review

    Cancio, M.; Ciccocioppo, R.; Rocco, P. R. M.; Levine, B. L.; Bronte, V.; Bollard, C. M.; Weiss, D.; Boelens, J. J.; Hanley, P. J.
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation
    Journal Article

    van Roessel, I.; Prockop, S.; Klein, E.; Boulad, F.; Scaradavou, A.; Spitzer, B.; Kung, A.; Curran, K.; O'Reilly, R. J.; Kernan, N. A.; more...
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Establishing cGMP manufacturing of CRISPR/Cas9-edited human CAR T cells
    Meeting Abstract

    Wang, X.; Zabierowski, S.; Wu, M.; Del Casale, C.; Eyquem, J.; Mansilla-Soto, J.; Riviere, I.; Sadelain, M.
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Treatment with banked 3rd party donor derived virus specific T cells: The advantages of pre-defined HLA restriction and epitope specificity
    Meeting Abstract

    Prockop, S.; Doubrovina, E.; Hasan, A.; O'Reilly, R. J.
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Epstein-Barr virus-specific cytotoxic T lymphocyte precursors (EBV-CTLp) after tabelecleucel correlates with response & survival in rituximab relapsing or refractory EBV posttransplant lymphoproliferative disease (PTLD)
    Meeting Abstract

    Prockop, S.; Shen, R. R.; Guzman-Becerra, N.; Sun, Y.; Forozan, F.; Doubrovina, E.; O'Reilly, R. J.; Li, X.; Hiremath, M.; Gamelin, L.; more...
    Cytotherapy (2020)

    Fulltext@MSK | Save

    • Elsevier Science Ltd. – authorized name for: